- cafead   Oct 19, 2023 at 11:52: AM
via
article source
- PTC Therapeutics has agreed to sell a big chunk of its remaining royalty stream from the spinal muscular atrophy drug Evrysdi to Royalty Pharma for $1 billion.
article source